ClinicalTrials.Veeva

Menu

Impact on Quality of Life 3 Years After Diagnosis of Prostate Cancer (EPICAP-QALY)

C

Centre Hospitalier Universitaire de Nīmes

Status

Completed

Conditions

Quality of Life
Prostatic Neoplasms

Treatments

Procedure: therapeutic management of the prostate Cancer as usual

Study type

Observational

Funder types

Other

Identifiers

NCT02854982
LIGUE/2014/NH-001

Details and patient eligibility

About

To study the quality of life of patients with prostate cancer at a distance from their care at a time when they are supposed to have taken a "normal" life and compared to subjects without cancer prostate of the same age.

Enrollment

900 patients

Sex

Male

Ages

Under 75 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

- exposed group

Inclusion Criteria:

  • prostate cancer diagnosed from 1 December 2011 to 31 December 2014
  • under 75 and residing in the Hérault department at diagnosis
  • recruited in the EPICAP study

Exclusion criteria:

  • having relapsed in the range
  • non-exposed group:

Inclusion Criteria:

  • controls (without prostate cancer) recruited in the EPICAP study
  • matched to cases on age (5 years)
  • residing in the Hérault department

Exclusion criteria:

  • diagnosis of prostate cancer set in the range

Trial design

900 participants in 2 patient groups

Prostate Cancer
Description:
Group drawn of the case group of the case control study, entitled EPICAP
Treatment:
Procedure: therapeutic management of the prostate Cancer as usual
No Prostate Cancer
Description:
Group drawn of the control group of the case control study, entitled EPICAP

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems